410 related articles for article (PubMed ID: 2475570)
1. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.
Davies A; Simmons DL; Hale G; Harrison RA; Tighe H; Lachmann PJ; Waldmann H
J Exp Med; 1989 Sep; 170(3):637-54. PubMed ID: 2475570
[TBL] [Abstract][Full Text] [Related]
2. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
3. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis.
Brooimans RA; van Wieringen PA; van Es LA; Daha MR
Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224
[TBL] [Abstract][Full Text] [Related]
4. H19, a surface membrane molecule involved in T-cell activation, inhibits channel formation by human complement.
Whitlow MB; Iida K; Stefanova I; Bernard A; Nussenzweig V
Cell Immunol; 1990 Mar; 126(1):176-84. PubMed ID: 1689219
[TBL] [Abstract][Full Text] [Related]
5. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule.
Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F
J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580
[TBL] [Abstract][Full Text] [Related]
6. CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis.
Brooimans RA; Van der Ark AA; Tomita M; Van Es LA; Daha MR
Eur J Immunol; 1992 Mar; 22(3):791-7. PubMed ID: 1372260
[TBL] [Abstract][Full Text] [Related]
7. Amplified gene expression in CD59-transfected Chinese hamster ovary cells confers protection against the membrane attack complex of human complement.
Zhao J; Rollins SA; Maher SE; Bothwell AL; Sims PJ
J Biol Chem; 1991 Jul; 266(20):13418-22. PubMed ID: 1712784
[TBL] [Abstract][Full Text] [Related]
8. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
[TBL] [Abstract][Full Text] [Related]
9. Protection of human amniotic epithelial cells (HAEC) from complement-mediated lysis: expression on the cells of three complement inhibitory membrane proteins.
Rooney IA; Morgan BP
Immunology; 1990 Nov; 71(3):308-11. PubMed ID: 1702747
[TBL] [Abstract][Full Text] [Related]
10. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
[TBL] [Abstract][Full Text] [Related]
11. Transfection of human CD59 complementary DNA into rat cells confers resistance to human complement.
Walsh LA; Tone M; Waldmann H
Eur J Immunol; 1991 Mar; 21(3):847-50. PubMed ID: 1707009
[TBL] [Abstract][Full Text] [Related]
12. Transfer of prostasomal CD59 to CD59-deficient red blood cells results in protection against complement-mediated hemolysis.
Babiker AA; Ronquist G; Nilsson UR; Nilsson B
Am J Reprod Immunol; 2002 Mar; 47(3):183-92. PubMed ID: 12069204
[TBL] [Abstract][Full Text] [Related]
13. Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity.
Brasoveanu LI; Altomonte M; Gloghini A; Fonsatti E; Coral S; Gasparollo A; Montagner R; Cattarossi I; Simonelli C; Cattelan A
Int J Cancer; 1995 May; 61(4):548-56. PubMed ID: 7538980
[TBL] [Abstract][Full Text] [Related]
14. Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity.
Ninomiya H; Stewart BH; Rollins SA; Zhao J; Bothwell AL; Sims PJ
J Biol Chem; 1992 Apr; 267(12):8404-10. PubMed ID: 1373727
[TBL] [Abstract][Full Text] [Related]
15. Identification of MIC 11 antigen as an epitope of the CD59 molecule.
Davies A; Wilson AB; Bramley JC; Willers C; Van Heyningen V; Bickmore WA; Lachmann PJ
Immunology; 1995 Jun; 85(2):220-7. PubMed ID: 7543876
[TBL] [Abstract][Full Text] [Related]
16. The CD59 antigen is a structural homologue of murine Ly-6 antigens but lacks interferon inducibility.
Philbrick WM; Palfree RG; Maher SE; Bridgett MM; Sirlin S; Bothwell AL
Eur J Immunol; 1990 Jan; 20(1):87-92. PubMed ID: 1689664
[TBL] [Abstract][Full Text] [Related]
17. Identification of a homologue of CD59 in a cyclostome: implications for the evolutionary development of the complement system.
dos Remedios NJ; Ramsland PA; Hook JW; Raison RL
Dev Comp Immunol; 1999; 23(1):1-14. PubMed ID: 10220064
[TBL] [Abstract][Full Text] [Related]
18. Protease-modified erythrocytes: CD55 and CD59 deficient PNH-like cells.
Yuan FF; Bryant JA; Fletcher A
Immunol Cell Biol; 1995 Feb; 73(1):66-72. PubMed ID: 7539403
[TBL] [Abstract][Full Text] [Related]
19. Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.
Schmitz J; Zimmer JP; Kluxen B; Aries S; Bögel M; Gigli I; Schmitz H
J Clin Invest; 1995 Sep; 96(3):1520-6. PubMed ID: 7544808
[TBL] [Abstract][Full Text] [Related]
20. CD59: a molecule involved in antigen presentation as well as downregulation of membrane attack complex.
Venneker GT; Asghar SS
Exp Clin Immunogenet; 1992; 9(1):33-47. PubMed ID: 1379443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]